Other Specified Anxiety Disorder: Meaning, Diagnosis, and Clinical Use
Updated: Oct 8
Author: Ukrainian Psychological Hub · Published: September 30, 2026 · Editorial Policy
Other Specified Anxiety Disorder is a formal clinical diagnosis used when anxiety symptoms are significant enough to cause clinically important distress or impairment, yet the presentation does not meet the full requirements for a more specific disorder in the anxiety-disorders class and the clinician can state why. In DSM-5-TR, the defining feature is not vague anxiety. It is a clinically meaningful anxiety presentation plus a specified reason that a named anxiety diagnosis is not the better fit. A current state-of-the-art review of anxiety classification summarizes the category in essentially this way: distressing or impairing anxiety symptoms are present, full criteria for another anxiety disorder are not met, and the clinician specifies the mismatch. Zbozinek, Khalsa, and Craske, 2026.
The word “specified” matters. It separates this diagnosis from Unspecified Anxiety Disorder, where anxiety is clinically significant but the clinician does not state the specific reason a named anxiety disorder is not diagnosed, often because available information is insufficient. DSM-5 replaced the older DSM-IV “not otherwise specified” approach with separate “other specified” and “unspecified” categories, a structural change described in the psychiatric literature. Advances in Psychopharmacology for Anxiety Disorders.
Other Specified Anxiety Disorder is therefore a residual category with a defined clinical function. “Residual” describes where it sits in a classification system; it does not mean trivial, imaginary, provisional, or automatically mild. Older studies of anxiety disorder not otherwise specified and newer research on subthreshold anxiety show that people who fall short of a named disorder threshold can still have substantial distress and functional impairment, although those research categories are not interchangeable with the current DSM-5-TR diagnosis. Comer et al., 2012; Witlox et al., 2021.
This article explains the diagnosis itself: what it means, when clinicians use it, what F41.8 represents in U.S. coding, how the DSM-5-TR concept relates to ICD-11 code 6B0Y, why Other Specified and Unspecified Anxiety Disorder are different, what must be considered before the diagnosis is made, and what the diagnosis does and does not imply about treatment.
Other Specified Anxiety Disorder at a glance
Other Specified Anxiety Disorder belongs to the DSM-5-TR Anxiety Disorders chapter. DSM is a clinical classification used by trained professionals, and the American Psychiatric Association emphasizes that its diagnostic criteria are intended to be applied with clinical judgment rather than used as a public self-diagnosis checklist. American Psychiatric Association: About DSM-5-TR.
• The symptoms are characteristically anxious or fear-related rather than merely ordinary stress, nervousness, or situational worry.
• The symptoms cause clinically significant distress or impairment in social, occupational, educational, family, or other important areas of functioning.
• The presentation does not meet the full criteria for a more specific anxiety disorder such as generalized anxiety disorder, panic disorder, agoraphobia, social anxiety disorder, specific phobia, separation anxiety disorder, or selective mutism.
• The presentation does not meet criteria for adjustment disorder with anxiety or adjustment disorder with mixed anxiety and depressed mood, a boundary incorporated into the current DSM formulation.
• A clinician can identify and document the specific reason the presentation falls outside a named anxiety-disorder category. That explicit reason is what makes the diagnosis “other specified.”
• In U.S. ICD-10-CM coding, F41.8 is the relevant code label, “Other specified anxiety disorders.” CMS FY 2026 ICD-10-CM/PCS MS-DRG Definitions Manual.
• In ICD-11, the closely corresponding category is 6B0Y, “Other specified anxiety or fear-related disorder.” The World Health Organization places it inside the Anxiety or fear-related disorders grouping. WHO ICD-11 Clinical Descriptions and Diagnostic Requirements.
• A high questionnaire score does not establish this diagnosis. Screening, symptom-severity measurement, clinical assessment, and formal diagnosis are different activities.
What “other specified” means in psychiatric diagnosis
DSM classifications contain named disorders with explicit criteria, but real clinical presentations do not always stop neatly at those thresholds. Someone may have a recognizable anxiety syndrome that is persistent, impairing, and clinically important while missing one requirement for a named disorder. Another person may have panic-like episodes that are clearly significant but do not satisfy the symptom threshold used for a full panic attack. A residual category gives clinicians a way to describe such presentations without pretending that criteria for another diagnosis have been met.
The “other specified” construction appears across DSM, not only in anxiety disorders. Its logic is consistent: the clinician identifies a clinically meaningful syndrome, determines that no named disorder in the relevant class fully captures it, and records why. The American Psychiatric Association describes DSM diagnosis as a process that includes criteria, differential diagnosis, clinical judgment, functional consequences, culture-related considerations, and comorbidity. American Psychiatric Association: About DSM-5-TR.
That makes Other Specified Anxiety Disorder more specific than a generic statement such as “the patient has anxiety.” Anxiety is a human experience and a symptom that appears in many medical and psychological contexts. The diagnosis refers to a defined clinical pattern that belongs in the anxiety-disorders diagnostic territory but does not fully match a named disorder.
Normal anxiety, symptoms, and a clinical disorder are different levels of description
Normal anxiety can arise before an examination, after receiving uncertain news, during conflict, or in response to a credible threat. Fear can be adaptive when danger is immediate. Worry can be a form of problem anticipation. A stress response can involve arousal, vigilance, muscle tension, faster breathing, or sleep disruption. None of those experiences automatically establishes a mental disorder.
A symptom becomes diagnostically relevant through its pattern: intensity, persistence, frequency, triggers, focus of apprehension, associated cognition, avoidance, safety behavior, functional impact, developmental context, cultural context, and relationship to other conditions. Other Specified Anxiety Disorder is considered only after that pattern is assessed and the clinician concludes that the anxiety presentation is clinically significant but does not fully satisfy another anxiety-disorder diagnosis.
For the broader distinction between ordinary anxiety and a diagnosable disorder, see Anxiety Disorders: Symptoms, Types, Diagnosis, and Treatment.
Where Other Specified Anxiety Disorder sits in DSM-5-TR
DSM-5-TR is the current text revision of DSM-5. The American Psychiatric Association describes DSM as having three components: diagnostic classification, diagnostic criteria sets, and descriptive text. Its codes are derived from ICD coding systems used in U.S. health care. American Psychiatric Association: About DSM-5-TR.
Within the Anxiety Disorders chapter, Other Specified Anxiety Disorder sits alongside named conditions and the separate Unspecified Anxiety Disorder category. OCD is not inside this chapter in current DSM classification; it belongs to obsessive-compulsive and related disorders. PTSD is not inside it either; it belongs to trauma- and stressor-related disorders. Illness anxiety disorder belongs to somatic symptom and related disorders. Those boundaries matter because anxiety can be prominent in all three without making them subtypes of Other Specified Anxiety Disorder.
For the full chapter map, see DSM-5-TR Anxiety Disorders: Classification and Diagnostic Categories.
F41.8 and the older 300.09 number
Many older DSM-5 articles, textbooks, and webpages display “300.09 (F41.8)” beside Other Specified Anxiety Disorder. The two numbers come from different generations of ICD coding. The American Psychiatric Association explicitly notes that there are no proprietary “DSM codes”: the codes printed in DSM come from ICD systems. The old numeric codes were ICD-9-CM codes, and U.S. claims moved to ICD-10-CM in 2015. APA DSM Frequently Asked Questions.
For contemporary U.S. coding, F41.8 is the relevant ICD-10-CM code. CMS lists F418 as “Other specified anxiety disorders” in the FY 2026 definitions manual. Centers for Medicare & Medicaid Services, 2026.
A coding label and a DSM diagnostic formulation should still not be treated as interchangeable pieces of text. ICD-10-CM is a health-care coding system with its own tabular structure and inclusion terms; DSM-5-TR is a diagnostic manual that uses ICD-10-CM codes within its clinical classification. The same F41.8 code can therefore appear in administrative data without telling a reader exactly what clinical reasoning was documented.
When clinicians use Other Specified Anxiety Disorder
The diagnosis becomes relevant when five questions converge.
First, are anxiety or fear symptoms genuinely the dominant clinical problem? A person can be distressed for many reasons. Anxiety can accompany depression, OCD, PTSD, substance use, medication effects, endocrine disease, arrhythmia, respiratory illness, neurologic disease, pain, sleep deprivation, or acute psychosocial stress. The label should not be selected simply because someone says “I feel anxious.”
Second, is the presentation clinically significant? Diagnostic classification is not intended to pathologize every ordinary fluctuation in fear or worry. The pattern must produce meaningful distress or impairment.
Third, does a named anxiety disorder fit better? A careful assessment checks the specific criteria and focus of apprehension associated with generalized anxiety disorder, panic disorder, agoraphobia, social anxiety disorder, specific phobia, separation anxiety disorder, and selective mutism rather than treating them as interchangeable expressions of anxiety.
Fourth, is another diagnostic family a better explanation? Current diagnostic practice separates OCD, trauma-related disorders, illness anxiety, depressive disorders, substance/medication-induced states, and anxiety due to another medical condition from the core anxiety-disorders chapter.
Fifth, if no named anxiety disorder fits fully, can the clinician state the reason? If yes, “other specified” may be appropriate. If the clinician cannot or does not state the reason, the “unspecified” category serves a different function.
This diagnostic logic is also reflected in current review literature, which distinguishes “other specified” from “unspecified” by whether the clinician specifies why a more specific anxiety diagnosis is not met. Zbozinek, Khalsa, and Craske, 2026.
DSM-5-TR examples of specified presentations
DSM-5-TR provides examples to illustrate how the category can be used. These are examples, not a complete list of every possible clinically defensible formulation. They also should not be turned into new standalone diagnoses.
Limited-symptom attacks
A limited-symptom attack is a panic-like episode that contains too few of the required symptoms to qualify as a full panic attack under the DSM panic-attack definition. The important point is the threshold mismatch. A person can experience sudden, frightening autonomic symptoms and behavior change without satisfying the full panic-attack symptom count.
That does not mean the person has panic disorder. Panic disorder requires a broader pattern centered on recurrent unexpected panic attacks and persistent concern or maladaptive behavior related to further attacks. Limited-symptom attacks therefore illustrate exactly why a residual diagnosis can be useful: clinically important panic-like phenomena exist below a named syndrome threshold.
Research on panic treatment has long distinguished full panic attacks from limited-symptom attacks in measurement, reinforcing that these are separable clinical phenomena rather than synonyms. Pollack et al., 1998.
Generalized anxiety occurring less often than “more days than not”
A second DSM example concerns a generalized-anxiety presentation in which anxiety and worry are clinically significant but occur less often than the “more days than not” frequency requirement used in DSM generalized anxiety disorder. The example is about a specific frequency threshold, not a declaration that any worry lasting less than six months automatically belongs here.
This distinction matters because diagnostic thresholds have several dimensions. Frequency, duration, number of associated symptoms, controllability, breadth of worry, functional impact, and exclusion criteria are not the same thing. A person can fall short of GAD for different reasons, and the documented reason should match the actual assessment.
Historical studies help explain why this issue matters clinically. In a DSM-IV-era sample, people with anxiety disorder not otherwise specified who resembled GAD still had clinically significant symptoms even though, on average, they reported less worry, negative affect, depression, and comorbidity than those with full GAD. Lawrence and Brown, 2009. The study predates DSM-5 and therefore does not estimate current Other Specified Anxiety Disorder, but it illustrates the threshold problem that residual categories were designed to address.
Khyâl cap and ataque de nervios
DSM has also used khyâl cap, often translated as “wind attacks,” and ataque de nervios, “attack of nerves,” as culturally informed examples in the Other Specified Anxiety Disorder discussion. These terms should be handled carefully. They describe cultural concepts of distress rather than universal biological syndromes with one automatic DSM mapping.
A culturally patterned experience is not converted into Other Specified Anxiety Disorder merely because an English-language manual lists the term. Assessment still asks what the person experiences, what the experience means in that cultural setting, whether it is culturally sanctioned or expected, how much impairment or distress it creates, and whether another diagnosis better accounts for the presentation. Classic epidemiologic work on ataque de nervios found that Puerto Rican respondents could report ataques within the panic section of a standard diagnostic interview, illustrating how a culturally meaningful category can overlap with, yet not be reducible to, a conventional diagnostic construct. Guarnaccia, Rubio-Stipec, and Canino, 1989.
This is an especially important boundary for online mental-health information. A cultural label can identify a meaningful experience without functioning as a standalone DSM disorder.
Other Specified Anxiety Disorder vs Unspecified Anxiety Disorder
The two diagnoses share one broad feature: clinically significant anxiety symptoms are present, yet criteria for a named anxiety disorder are not fully met. The difference lies in what the clinician communicates.
Other Specified Anxiety Disorder
With Other Specified Anxiety Disorder, the clinician identifies the reason a named diagnosis is not met and records it. The formulation is therefore diagnostically informative. Examples include a panic-like presentation with insufficient symptoms for a full panic attack or a generalized-anxiety presentation that misses the required frequency threshold.
Unspecified Anxiety Disorder
With Unspecified Anxiety Disorder, the clinician does not state the specific reason a named disorder is not met. One practical context is an evaluation in which there is not enough information yet to make a more specific determination. “Unspecified” can therefore be appropriate when the anxiety is clearly clinically significant but diagnostic specificity is not available or not being communicated.
Specified does not mean “more severe”
The words specified and unspecified describe diagnostic information, not severity. An unspecified presentation can be severe. An other-specified presentation can be moderate or severe, and it can also be less symptomatically extensive than a named disorder while remaining clinically impairing. Severity has to be assessed independently.
Specified does not mean “almost GAD”
Many people encounter the term through a GAD-like example, but the category is not a synonym for subthreshold generalized anxiety disorder. It can capture several different anxiety presentations. Treating it as “GAD lite” erases the reason the residual category exists.
A dedicated Unspecified Anxiety Disorder article is reserved in the English Hub and will own that narrower intent when published. Until then, this article keeps the distinction conceptual without sending readers to an inactive page.
Other Specified Anxiety Disorder in ICD-11
ICD-11 uses the formal category “Other specified anxiety or fear-related disorder,” code 6B0Y. The wording is close to DSM-5-TR but belongs to a separate classification system. WHO’s 2024 Clinical Descriptions and Diagnostic Requirements places 6B0Y within “Anxiety or fear-related disorders,” after selective mutism and before 6B0Z, “Anxiety or fear-related disorder, unspecified.” World Health Organization, 2024.
The WHO framework requires an anxiety presentation that shares primary clinical features with the anxiety/fear-related family, does not fulfill the requirements for another disorder in that grouping, is not better accounted for by another mental disorder, is not developmentally appropriate or culturally sanctioned, and is not better explained by a medical condition, substance, medication, or withdrawal. The classification also requires clinically meaningful distress or impairment within its family-level definition.
ICD-11 additionally allows the presence of panic attacks to be coded with 6B0Y when panic attacks occur without a co-occurring panic disorder diagnosis. WHO lists the combination 6B0Y/MB23.H for “Other specified anxiety and fear-related disorder with panic attacks.” WHO ICD-11 CDDR.
DSM-5-TR F41.8 and ICD-11 6B0Y are related, not interchangeable codes
The conceptual roles are similar: both systems need a place for clinically significant anxiety/fear presentations that are specified but do not meet another named diagnosis in the family. The code systems are different, however. F41.8 is an ICD-10-CM code used in current U.S. coding. 6B0Y is an ICD-11 code. A clinician, health system, researcher, or insurer must use the coding system applicable to the jurisdiction and purpose rather than substituting one code for the other.
For a broader cross-system map, see DSM-5-TR vs ICD-11 Anxiety Disorders: Key Classification Differences and ICD-11 Anxiety Classification: Anxiety or Fear-Related Disorders.
How Other Specified Anxiety Disorder is diagnosed
There is no single blood test, brain scan, online quiz, or questionnaire score that determines Other Specified Anxiety Disorder. Diagnosis is a clinical classification decision built from multiple kinds of information.
1. Characterize the anxiety presentation
Assessment begins by describing what actually happens. Is the dominant experience apprehensive worry, abrupt panic-like episodes, fear of scrutiny, fear tied to a circumscribed object or situation, fear of being unable to escape or get help, fear of separation, or another pattern? What thoughts accompany it? What does the person predict will happen? What does the person avoid? What safety behaviors are used?
The “focus of apprehension” is an important organizing idea in anxiety classification. Different anxiety disorders are partly distinguished by what the fear or anxiety is about, not simply by how intense a generic anxiety rating is. The ICD-11 development literature emphasizes this structure. Kogan et al., 2016.
2. Establish clinical significance
The clinician assesses distress and functional impairment. A diagnosis is not justified merely because anxiety exists. Questions include whether symptoms disrupt sleep, concentration, attendance, work, school, relationships, travel, medical care, caregiving, social participation, or ordinary daily activities.
Impairment can be substantial even when a person misses a categorical threshold. That point is supported by older NOS and subthreshold-anxiety research, but the research categories are heterogeneous and should not be treated as exact synonyms for the current diagnosis. Comer et al., 2012; Witlox et al., 2021.
3. Test named anxiety disorders before using the residual category
A residual diagnosis should not replace adequate assessment of named disorders. The clinician checks whether the presentation meets generalized anxiety disorder, panic disorder, agoraphobia, social anxiety disorder, specific phobia, separation anxiety disorder, selective mutism, substance/medication-induced anxiety disorder, or anxiety disorder due to another medical condition where appropriate.
If a named diagnosis is met, that diagnosis usually carries more information about expected course, differential diagnosis, and treatment evidence than a residual label.
4. Identify the exact missing or atypical feature
For “other specified,” the clinician should be able to articulate the mismatch. It might be insufficient panic symptoms, a frequency threshold that is not met, an atypical but clinically significant anxiety pattern, or another specified reason supported by the assessment.
This is the practical center of the diagnosis. If the chart merely says “anxiety symptoms” with no explanation of why a more specific diagnosis does not apply, that documentation does not communicate the function of an “other specified” formulation very well.
5. Evaluate differential diagnoses and medical explanations
Anxiety symptoms can arise from psychiatric, neurologic, endocrine, cardiovascular, respiratory, substance-related, and medication-related causes. A psychiatric review on anxiety diagnosis specifically notes the need to consider conditions such as hyperthyroidism, stimulant or caffeine overuse, anemia, cardiac disease, respiratory disease, and neurologic disorders. Morbid Anxiety: Identification and Treatment.
The scope of medical workup depends on the symptoms, age, history, medications, substance exposure, onset, physical examination, and clinical context. An online article cannot safely determine whether palpitations, chest discomfort, shortness of breath, dizziness, fainting, tremor, weakness, or neurologic symptoms are caused by anxiety.
6. Consider developmental and cultural context
A fear that is developmentally expected at one age may be clinically unusual at another. A behavior that appears avoidant in one cultural setting may have a different meaning in another. Both DSM and ICD approaches incorporate developmental and cultural interpretation into diagnosis.
Cultural formulation is especially important when a person describes distress through culturally specific concepts such as ataque de nervios. The task is to understand the experience and its context, not to translate a cultural phrase mechanically into a diagnostic code.
Screening is not diagnosis
People sometimes search for an “Other Specified Anxiety Disorder test.” There is no single validated questionnaire that independently diagnoses this category. Measures such as the GAD-7, Beck Anxiety Inventory, Hamilton Anxiety Rating Scale, OASIS, SCARED, SPIN, or Liebowitz Social Anxiety Scale can serve different purposes, including screening, symptom measurement, research, or monitoring. Their scores do not determine whether a person belongs in Other Specified Anxiety Disorder.
The American Psychiatric Association’s own assessment-measures program distinguishes disorder-specific severity measures from diagnostic classification and explicitly frames these tools as aids to further clinical evaluation and research. APA DSM-5-TR Online Assessment Measures.
A score may show that symptoms are frequent or severe. It does not establish which diagnostic family best explains them, whether a medical or substance-related condition is involved, whether a named anxiety disorder is met, or whether the clinician can identify the specific reason for an other-specified diagnosis.
Research on “subthreshold anxiety” also illustrates why a questionnaire threshold and a DSM diagnosis should not be equated. One large study found no natural cutoff that cleanly defined clinically relevant subthreshold anxiety and described its proposed Beck Anxiety Inventory cutoff as somewhat arbitrary. Karsten et al., 2011. That is a measurement finding, not a diagnostic rule for Other Specified Anxiety Disorder.
Differential diagnosis: what has to be separated from Other Specified Anxiety Disorder
The differential is not a formality. The diagnosis is defined partly by what the presentation does not better fit.
Generalized Anxiety Disorder
GAD is its own diagnostic territory. In DSM-5-TR, the syndrome is organized around excessive anxiety and worry across multiple areas, difficulty controlling the worry, associated symptoms, a sustained course, and clinically significant distress or impairment. A person whose presentation meets GAD should not be moved into Other Specified Anxiety Disorder merely because the clinician prefers a broader label.
Conversely, a GAD-like presentation can be other-specified when a specific criterion is not met and the clinician documents the reason. The classic DSM example is generalized anxiety occurring less often than “more days than not.”
Panic Disorder and panic attacks
A panic attack is not a diagnosis by itself, and panic disorder is not defined by any episode of intense anxiety. Panic disorder requires its own longitudinal pattern. Other Specified Anxiety Disorder may be relevant to panic-like presentations that fall below a threshold, but the reason must be precise.
Sudden chest pain, marked shortness of breath, syncope, new neurologic deficits, or other acute physical symptoms also require appropriate medical assessment. Symptom overlap with panic is not evidence that a medical emergency is “just anxiety.”
Agoraphobia
Agoraphobia is defined by a characteristic pattern of fear or anxiety across particular situations related to concerns about escape or access to help if incapacitating or embarrassing symptoms occur. If that pattern meets the diagnostic criteria, Other Specified Anxiety Disorder is not a substitute for agoraphobia.
Social Anxiety Disorder
Social anxiety disorder is organized around fear of scrutiny, negative evaluation, embarrassment, rejection, or visible anxiety in social or performance situations. General social discomfort, low confidence, introversion, or nervousness around people does not automatically meet the diagnosis. Other Specified Anxiety Disorder should be considered only when a clinically significant anxiety presentation remains after the named criteria are assessed.
Specific Phobia
Specific phobia has its own diagnostic territory centered on a circumscribed object or situation, marked fear or anxiety, avoidance or intense endurance, disproportionality, persistence, and impairment. Popular Greek-derived names for fears are not independent DSM diagnoses. If the clinical pattern meets specific phobia, the specific-phobia diagnosis owns that territory.
Separation Anxiety Disorder and Selective Mutism
Both are formal anxiety-disorder diagnoses in DSM-5-TR and anxiety/fear-related diagnoses in ICD-11. Their presence in the current anxiety family means that residual categories should not be used simply because the patient is an adult, because symptoms began in childhood, or because the presentation looks unusual at first glance. The named diagnostic requirements must be considered directly.
Adjustment Disorder with anxiety
This is a particularly important boundary. Current DSM wording for Other Specified and Unspecified Anxiety Disorder excludes presentations that meet adjustment disorder with anxiety or adjustment disorder with mixed anxiety and depressed mood. A stress-related onset therefore cannot be ignored.
The distinction depends on the full relationship between an identifiable stressor, timing, symptom pattern, proportionality, functional impact, and whether another disorder better explains the symptoms. “It started after stress” is not enough by itself to decide between the categories.
Substance/Medication-Induced Anxiety Disorder
Stimulants, caffeine, withdrawal states, medications, and other substances can produce or amplify anxiety symptoms. A diagnosis in the core anxiety family should not be made without considering temporal relationships to substances and medications when clinically relevant.
Anxiety Disorder Due to Another Medical Condition
Endocrine, cardiac, respiratory, neurologic, and other medical conditions can present with anxiety-like symptoms. The relevant diagnosis depends on evidence that the anxiety is a direct pathophysiological consequence of the medical condition, not simply on the fact that a person has both a medical illness and anxiety.
OCD, PTSD, and illness anxiety
OCD can involve intense anxiety around obsessions and compulsions, PTSD can include hyperarousal and fear, and illness anxiety can involve persistent health-related anxiety. In current DSM and ICD classification, these conditions are not simply subtypes of anxiety disorder. Their own symptom organization and diagnostic families must be assessed.
The same principle applies to attachment anxiety, neuroticism, and historical “anxiety neurosis.” These terms can be useful in relationship research, personality science, or the history of psychiatry, but they are not alternate names for Other Specified Anxiety Disorder.
Physical symptoms: why medical differential diagnosis still matters
Anxiety can be accompanied by autonomic and somatic symptoms: palpitations, sweating, trembling, shortness of breath, chest discomfort, nausea, dizziness, tingling, muscle tension, fatigue, sleep disturbance, and gastrointestinal symptoms. Those symptoms are psychologically real and can be intense.
They are also nonspecific. Similar symptoms can arise in arrhythmias, asthma and other respiratory conditions, thyroid disorders, anemia, vestibular problems, medication effects, stimulant use, withdrawal states, neurologic conditions, dehydration, infection, and many other medical situations. A psychiatric diagnosis cannot be established from symptom resemblance alone.
New, severe, rapidly worsening, or atypical chest pain, significant breathing difficulty, fainting, new weakness, new speech difficulty, severe confusion, or other acute neurologic or cardiopulmonary symptoms warrant prompt medical evaluation rather than an online assumption that anxiety is the cause.
This safety boundary applies equally to Other Specified Anxiety Disorder and to named anxiety disorders. Having a psychiatric history does not make every later physical symptom psychiatric.
Does “other specified” mean the anxiety is mild?
No. Missing a categorical threshold and having mild symptoms are different ideas.
Diagnostic criteria contain thresholds for pattern, frequency, duration, number of symptoms, context, and functional impact. A person can miss one formal criterion while still experiencing substantial disability. Historical evidence illustrates this point. In a structured study of 650 treatment-seeking anxious youth under DSM-IV, roughly 15% received anxiety disorder not otherwise specified, and their overall clinical problems were comparable in several respects with those of youth who had specified anxiety disorders. Comer et al., 2012.
Another DSM-IV-era study comparing people with anxiety disorder NOS that resembled GAD with people who had full GAD found clinically significant symptoms in the NOS group, although the GAD group showed greater worry, negative affect, depression, and comorbidity on average. Lawrence and Brown, 2009.
These studies should be interpreted historically. DSM-IV anxiety disorder NOS was not the same category as DSM-5-TR Other Specified Anxiety Disorder. Their value is narrower: they show why “below a named diagnostic threshold” should not be casually translated into “clinically unimportant.”
How common is Other Specified Anxiety Disorder?
There is no single robust population prevalence estimate that can be treated as the prevalence of current DSM-5-TR Other Specified Anxiety Disorder across the general population.
That limitation has several causes. Older epidemiology often used DSM-IV anxiety disorder NOS. Many contemporary studies use research constructs such as “subthreshold anxiety,” “subsyndromal GAD,” or symptom-scale cutoffs. Those constructs overlap conceptually with residual anxiety presentations but are not identical to Other Specified Anxiety Disorder. Different studies also use different thresholds, populations, interviews, and exclusion rules.
A U.S. government-supported analysis of survey design explicitly noted that past-year prevalence estimates for DSM-5 “other specified” disorders were unavailable and that these categories can be difficult to assess in large surveys. NCBI Bookshelf: Impact of the DSM-IV to DSM-5 Changes.
Systematic evidence does show that subthreshold anxiety is common in some populations. A meta-analysis in adults age 55 and older found subthreshold panic, generalized anxiety, and specific phobia more prevalent than their corresponding full disorders in the included literature, while also emphasizing substantial heterogeneity and a limited number of usable samples. Witlox et al., 2021. That result should not be relabeled as the prevalence of Other Specified Anxiety Disorder.
Treatment: the diagnosis does not dictate one protocol
There is no single treatment package that follows automatically from the words “Other Specified Anxiety Disorder.” The category is heterogeneous by design. A person with panic-like episodes below threshold may need a different formulation from a person with broad worry that misses a GAD frequency criterion or a culturally patterned anxiety presentation.
The first treatment task is therefore diagnostic and functional: identify the dominant symptoms, maintaining processes, avoidance, safety behavior, impairment, medical or substance contributors, comorbidity, patient goals, and the closest well-supported clinical formulation.
Psychotherapy
Cognitive behavioral therapy is a major evidence-based treatment family for anxiety disorders, but its components are selected according to the problem. Exposure is central for many fear-based conditions; interoceptive exposure has a particular role in panic-focused treatment; behavioral experiments may target catastrophic predictions; cognitive and behavioral strategies for chronic worry differ from exposure to a circumscribed phobic object.
Current reviews also emphasize that treatment evidence is disorder-specific and that even promising newer interventions vary greatly in maturity of evidence. Zbozinek, Khalsa, and Craske, 2026.
For an other-specified presentation, it can be reasonable for a clinician to draw on the evidence base for the closest validated syndrome or mechanism, but the transfer has to be explicit rather than automatic. Evidence for panic disorder cannot simply be relabeled evidence for every panic-like presentation, and evidence for GAD cannot be generalized to every residual anxiety state.
Medication
Medication decisions likewise depend on the actual clinical formulation, symptom burden, comorbidity, medical history, age, pregnancy status where relevant, other medicines, substance-use risk, adverse effects, monitoring needs, and patient preferences. The F41.8 code does not itself tell a prescriber which medication to use.
This is one reason an educational article should not transform a residual diagnostic label into an individualized prescription. Medication evidence is much stronger for several named anxiety disorders than for the heterogeneous DSM-5-TR Other Specified category.
Evidence from “subthreshold anxiety” is not automatically OSAD evidence
Trials and meta-analyses sometimes study “subthreshold anxiety” using broader definitions that may include older NOS diagnoses, mixed anxiety-depressive presentations, or symptom thresholds. For example, a meta-analysis of an oral lavender preparation pooled several subthreshold-anxiety trial populations rather than a clean DSM-5-TR OSAD cohort. Möller et al., 2019.
That research can inform questions about clinically significant anxiety below full syndrome thresholds. It does not create a universal treatment recommendation for Other Specified Anxiety Disorder, and it should not be used to self-select a medication or supplement.
Can the diagnosis change over time?
Yes. Psychiatric diagnosis is based on the best available information about a person’s current and longitudinal presentation. More information can clarify a previously uncertain pattern. Symptoms can also evolve.
Someone initially diagnosed with Other Specified Anxiety Disorder may later meet criteria for a named anxiety disorder if the pattern becomes clearer or crosses a threshold. Another person may improve and no longer meet criteria for any disorder. In other cases, further assessment may reveal that the better explanation is a different diagnostic family, a medical condition, a substance or medication effect, or an adjustment-related syndrome.
That does not mean Other Specified Anxiety Disorder is inherently a “temporary” or “provisional” diagnosis. It is a legitimate diagnosis when its criteria and recording logic are satisfied. The point is that diagnoses can be revised when the clinical evidence changes.
Common misunderstandings
“It means the clinician does not know what is wrong”
Not necessarily. Other Specified Anxiety Disorder specifically allows the clinician to state what is known: anxiety is clinically significant, a named anxiety disorder is not fully met, and there is an identifiable reason for the mismatch. Unspecified Anxiety Disorder is the category more directly associated with not communicating the reason or having insufficient information.
“It is just another name for generalized anxiety disorder”
No. GAD is a named diagnosis with its own criteria. A GAD-like presentation can be one route to an other-specified diagnosis, but the category also includes other patterns.
“It is the same as anxiety disorder NOS”
Not exactly. DSM-IV used anxiety disorder not otherwise specified. DSM-5 split that residual territory into Other Specified Anxiety Disorder and Unspecified Anxiety Disorder, preserving a distinction between a stated reason and an unstated or insufficiently known reason. Advances in Psychopharmacology for Anxiety Disorders.
“F41.8 tells you the exact symptoms”
No. F41.8 is a code. It does not, by itself, reveal which symptoms are present, which named diagnosis was considered, which criterion was missing, how severe the impairment is, or what treatment is appropriate. Clinical documentation provides that information.
“A GAD-7 score can prove the diagnosis”
No. A GAD-7 result is a screening or severity measurement, depending on how it is used. Other Specified Anxiety Disorder requires diagnostic reasoning about the whole presentation and its differential.
“If symptoms are below threshold, treatment is unnecessary”
No. Clinical need is determined by distress, impairment, risk, course, and the person’s goals, not only by whether every criterion for a named syndrome is met. Subthreshold-anxiety research repeatedly shows that below-threshold presentations can still be consequential.
When professional assessment is especially useful
Professional assessment is worth considering when anxiety, fear, panic-like episodes, avoidance, or worry persist; interfere with work, education, relationships, sleep, travel, medical care, or daily functioning; lead to escalating substance use or reliance on safety behaviors; or are difficult to explain from context alone.
Medical assessment is particularly important when physical symptoms are new, severe, atypical, or potentially cardiopulmonary or neurologic. A prior anxiety diagnosis does not rule out a new medical problem.
If anxiety occurs alongside thoughts of self-harm or suicide, inability to stay safe, severe agitation, psychosis, mania-like symptoms, or dangerous substance use, assessment should focus on immediate safety and the full clinical picture rather than on deciding whether the residual anxiety category fits.
Frequently asked questions
Is Other Specified Anxiety Disorder a real diagnosis?
Yes. It is a formal DSM-5-TR diagnosis within the Anxiety Disorders chapter. ICD-11 has a closely corresponding category called Other specified anxiety or fear-related disorder, code 6B0Y. The diagnosis is used for clinically significant anxiety presentations that do not meet a more specific anxiety diagnosis when the clinician can state why.
What is the ICD-10-CM code for Other Specified Anxiety Disorder?
In current U.S. ICD-10-CM coding, F41.8 is “Other specified anxiety disorders.” CMS lists F418 in its FY 2026 coding materials. Older DSM-5-era sources may also display 300.09, an ICD-9-CM-era number that is no longer the code used for U.S. claims. CMS, 2026; APA DSM FAQ.
What is the difference between Other Specified and Unspecified Anxiety Disorder?
Both can be used when clinically significant anxiety does not meet a named anxiety disorder. In Other Specified Anxiety Disorder, the clinician states the reason. In Unspecified Anxiety Disorder, the clinician does not specify the reason or there is insufficient information for greater diagnostic specificity.
Does Other Specified Anxiety Disorder mean subthreshold anxiety?
It can overlap with what researchers call subthreshold or subsyndromal anxiety, but the terms are not identical. “Subthreshold anxiety” is used with many different research definitions. Other Specified Anxiety Disorder is a DSM clinical diagnosis with a particular recording logic.
Can Other Specified Anxiety Disorder include panic attacks?
It can involve panic-like phenomena, including DSM’s example of limited-symptom attacks. A full panic attack can also occur in many disorders without establishing panic disorder. ICD-11 specifically permits panic attacks to be coded with 6B0Y when panic disorder is not also diagnosed. WHO ICD-11 CDDR.
Can it later become Generalized Anxiety Disorder or Panic Disorder?
A diagnosis can be revised if the symptom pattern, course, or available information changes. That does not mean progression is inevitable. Some people improve, some remain in a residual pattern, and some later meet criteria for another diagnosis.
Is Other Specified Anxiety Disorder less serious than GAD or Panic Disorder?
The label does not determine severity. Some residual presentations are less extensive than a named disorder; others are substantially impairing despite missing one formal criterion. Severity and functional impact have to be assessed directly.
Is there an Other Specified Anxiety Disorder test?
No single questionnaire diagnoses it. Screening and severity scales can measure symptoms, but diagnosis requires clinical assessment of the anxiety pattern, impairment, named disorder criteria, differential diagnoses, medical and substance factors, and the reason a more specific diagnosis is not met.
Is F41.8 the same thing as ICD-11 6B0Y?
They occupy related clinical territory, but they are codes from different ICD systems. F41.8 is used in U.S. ICD-10-CM coding; 6B0Y is the ICD-11 code for Other specified anxiety or fear-related disorder. They should not be substituted mechanically across coding environments.
The bottom line
Other Specified Anxiety Disorder is a formal way to diagnose clinically significant anxiety that belongs in the anxiety-disorders territory but does not fully match a named disorder when the clinician can explain why. The category preserves diagnostic precision without forcing a person into criteria that are not actually met.
Its most important boundaries are equally clear. Ordinary anxiety is not automatically a disorder. A screening score is not a diagnosis. Panic-like symptoms are not automatically panic disorder. OCD, PTSD, illness anxiety, adjustment disorder, substance/medication-induced anxiety, and anxiety due to a medical condition require their own diagnostic consideration. Physical symptoms should not be attributed to anxiety by resemblance alone.
The most useful clinical question is therefore not “Which anxiety label sounds closest?” It is “What is the actual pattern, what impairment does it cause, which named diagnoses have been tested, what competing explanations have been evaluated, and what specific reason remains for using the other-specified category?”
Related Articles
References